Literature DB >> 219209

Characterization of an Epstein-Barr virus-induced DNA polymerase.

T Ooka, G Lenoir, J Daillie.   

Abstract

The addition of iododeoxyuridine to P3HR-I cell cultures led to a large increase in both Epstein-Barr virus (EBV)-induced DNA polymerase activity and early antigen-positive cells. This EBV-induced DNA polymerase was separated from the cellular alpha- and beta-polymerases by sequential column chromatography on Sepharose 6B, DEAE-cellulose, and phosphocellulose, resulting in partial purification of about 320-fold. The partially purified-EBV DNA polymerase could be distinguished from the cellular DNA polymerases by its activation by salts, its catalytic properties, and its degree of sensitivity to N-ethylmaleimide, phosphonoacetic acid, araATP, and araCTP. The viral polymerase showed properteis similar to those reported for other herpesvirus DNA polymerases. The enzyme exhibited optimal activity for copying activated calf DNA in the presence of 50 mH (NH4)2SO4 and was resistant to 150 mM (NH4)2SO4. It utilized with high efficiency template-primer poly(dC)-oligo(dG)12-18 or poly(dA)-oligo(dT)12-18, but failed to copy poly(rA)-oligo(dT)10 and oligo(dT)10, indicating that this enzyme has characters distinct from DNA polymerase gamma, reverse transcriptase, and terminal deoxynucleotidyl transferase. Phosphonacetic acid inhibited not only EBV DNA polymerase, but also, to a lesser degree, the cellular polymerase alpha. AraATP did not severely inhibit viral activity, whereas the polymerase alpha was inhibited most effectively. Both EBV polymerase and polymerase alpha were inhibited at a comparable level by araCTP.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219209      PMCID: PMC353059     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Studies of an Epstein-Barr virus-induced DNA polymerase.

Authors:  R L Miller; R Glaser; F Rapp
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

2.  Purification and characterization of equine herpesvirus-induced DNA.

Authors:  G P Allen; D J O'Callaghan; C C Randall
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

3.  A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.

Authors:  J V PULVERTAFT
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

4.  Inhibition of herpes simplex virus replication by phosphonoacetic acid.

Authors:  L R Overby; E E Robishaw; J B Schleicher; A Rueter; N L Shipkowitz; J C Mao
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

5.  Variation of DNA polymerase and RNA polymerase activities in cells infected with herpes simplex virus type 1.

Authors:  W E Müller; R K Zahn; D Falke
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

6.  Nonstructural proteins of herpes simplex virus. I. Purification of the induced DNA polymerase.

Authors:  K L Powell; D J Purifoy
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

7.  Varicella-zoster virus-induced DNA polymerase.

Authors:  R L Miller; F Rapp
Journal:  J Gen Virol       Date:  1977-09       Impact factor: 3.891

8.  Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.

Authors:  P M Schwartz; C Shipman; J C Drach
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

9.  Synthesis of Epstein-Barr virus DNA in vitro: effects of phosphonoacetic acid, N-ethylmaleimide, and ATP.

Authors:  T Seebeck; J E Shaw; J S Pagano
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

10.  Marek's disease herpesvirus-induced DNA polymerase.

Authors:  L F Lee; J A Boezi; R W Blakesley; M Koenig; H C Towle
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

View more
  14 in total

1.  2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent.

Authors:  C Lopez; K A Watanabe; J J Fox
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

2.  The characterization of the EBV alkaline deoxyribonuclease cloned and expressed in E. coli.

Authors:  S A Baylis; D J Purifoy; E Littler
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

3.  Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells.

Authors:  B Kallin; L Sternås; A K Saemundssen; J Luka; H Jörnvall; B Eriksson; P Z Tao; M T Nilsson; G Klein
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Characterization of an Epstein-Barr virus-induced thymidine kinase.

Authors:  M de Turenne-Tessier; T Ooka; G de The; J Daillie
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  Identification and characterization of a DNase induced by Epstein-Barr virus.

Authors:  R S Tan; A K Datta; Y C Cheng
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

6.  Cellular and Epstein-Barr virus specific DNA polymerases in virus-producing Burkitt's lymphoma cell lines.

Authors:  H S Allaudeen; G Rani
Journal:  Nucleic Acids Res       Date:  1982-04-10       Impact factor: 16.971

7.  Induced hydrolytic activity of yeast phenylalanyl-tRNA synthetase by tRNAPhe-CC.

Authors:  W Kuhn; F W Schneider
Journal:  Nucleic Acids Res       Date:  1982-04-10       Impact factor: 16.971

8.  The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.

Authors:  G Decaussin; V Leclerc; T Ooka
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Effect of arabinofuranosylthymine on the replication of Epstein-Barr virus and relationship with a new induced thymidine kinase activity.

Authors:  T Ooka; A Calender; M de Turenne; J Daillie
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

10.  Polypeptide synthesis and phosphorylation in Epstein-Barr virus-infected cells.

Authors:  R J Feighny; M P Farrell; J S Pagano
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.